“Exploring the Potential of Drug Repurposing: Detection of Cystic Fibrosis Transmembrane Conductance Regulator as a Biomarker in Breast Cancer Patients” (2023) Precision Medicine Communications, 3(1), pp. 11–26. doi:10.55627/pmc.003.01.0300.